Vaccinogen, Inc. (OTCQB: VGEN) is a cancer vaccine company that is clinically testing its OncoVAX® treatment, which is designed to prevent the recurrence of colon cancer. The treatment is a patented process that leverages the patient’s own live tumor cells to launch a broad immune response against colon cancer. Five clinical studies of OncoVAX®, including a Phase II trial with optimum dose and regimen, have been completed to date. For more information, visit the company’s website at www.vaccinogeninc.com.

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its tenth annual equity conference in Sandpiper Bay, FL. Attended by institutional investors from across North America, the event features more than 140 public company executive teams from a diverse range of industries. For more information, visit www.noble.missionir.com.